Human medicines European public assessment report (EPAR): Invanz, ertapenem, Date of authorisation: 18/04/2002, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Obizur, susoctocog alfa, Date of authorisation: 11/11/2015, Revision: 13, Status: Authorised
List of medicines currently in PRIME scheme
Recommendations on eligibility to PRIME scheme adopted at the CHMP meeting of 10-13 November 2025
Antimicrobial resistance in human medicine
Human medicines European public assessment report (EPAR): Yselty, linzagolix choline, Date of authorisation: 14/06/2022, Revision: 6, Status: Authorised
Regulatory Procedure Management in IRIS roadmap
Minutes of the PRAC meeting 29 September - 2 October 2025
Minutes – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 20 October 2025
Minutes of the HMPC meeting 22-24 September 2025